国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
2期
43-45
,共3页
抑郁症%焦虑障碍%度洛西汀%帕罗西汀
抑鬱癥%焦慮障礙%度洛西汀%帕囉西汀
억욱증%초필장애%도락서정%파라서정
Depression%Anxiety disorder%Duloxetine%Paroxetine
目的 比较度洛西汀与帕罗西汀治疗抑郁伴焦虑障碍的疗效和安全性.方法 对24例符合CCMD-3抑郁发作和广泛性焦虑诊断标准的患者随机双盲进入度洛西汀或帕罗西汀组治疗6周,分别在治疗前及第1、2、4、6周末进行汉密尔顿抑郁量表17项(HAMD)、汉密尔顿焦虑量表(HAMA)和临床疗效总评量表的病情严重程度(CGI-SI)评定,进行体格检查、实验室检查,及采用副反应量表(TESS)评估用药安全性.结果 经6周治疗后显示,度洛西汀总体疗效比帕罗西汀稍好且起效快,效果良好,在治疗第1周末HAMD总分与帕罗西汀组有显著性差异(P<0.05).两组不良反应均较轻微.结论 度洛西汀抗抑郁及抗焦虑作用确切,可用于治疗抑郁症伴焦虑障碍.
目的 比較度洛西汀與帕囉西汀治療抑鬱伴焦慮障礙的療效和安全性.方法 對24例符閤CCMD-3抑鬱髮作和廣汎性焦慮診斷標準的患者隨機雙盲進入度洛西汀或帕囉西汀組治療6週,分彆在治療前及第1、2、4、6週末進行漢密爾頓抑鬱量錶17項(HAMD)、漢密爾頓焦慮量錶(HAMA)和臨床療效總評量錶的病情嚴重程度(CGI-SI)評定,進行體格檢查、實驗室檢查,及採用副反應量錶(TESS)評估用藥安全性.結果 經6週治療後顯示,度洛西汀總體療效比帕囉西汀稍好且起效快,效果良好,在治療第1週末HAMD總分與帕囉西汀組有顯著性差異(P<0.05).兩組不良反應均較輕微.結論 度洛西汀抗抑鬱及抗焦慮作用確切,可用于治療抑鬱癥伴焦慮障礙.
목적 비교도락서정여파라서정치료억욱반초필장애적료효화안전성.방법 대24례부합CCMD-3억욱발작화엄범성초필진단표준적환자수궤쌍맹진입도락서정혹파라서정조치료6주,분별재치료전급제1、2、4、6주말진행한밀이돈억욱량표17항(HAMD)、한밀이돈초필량표(HAMA)화림상료효총평량표적병정엄중정도(CGI-SI)평정,진행체격검사、실험실검사,급채용부반응량표(TESS)평고용약안전성.결과 경6주치료후현시,도락서정총체료효비파라서정초호차기효쾌,효과량호,재치료제1주말HAMD총분여파라서정조유현저성차이(P<0.05).량조불량반응균교경미.결론 도락서정항억욱급항초필작용학절,가용우치료억욱증반초필장애.
Objective To control the efficacy of duloxetine and paroxetine in treatment of co-occurring depression and anxiety disorder.Methods 24 patients with a diagnosis of major depressive episode and anxiety disorder(CCMD-3)were randomly assigned to 6 weeks of treatment with duloxetine or paroxetine in double-blind.The efficacy was assessed with HAMD-17、HAMA and CGI-SI at the end of baseline and 1,2,4,6 weeks after
treatment.Safety was estimated by TESS,laboratory and physical examination.Results After 6 weeks treatment,the result based on the reduction rate of HAMD and HAMA showed duloxetine was comparably effective as paroxetine.The HAMD scores decreased significantly at the end of 1 week after treatment between two groups(p<0.05).The adverse effects were mild.Conclusions Duloxetine has positive effectiveness in co-occurring depression and anxiety disorder.